Remedium Bio
Pre-clinicalDevelops gene therapies for neurodegenerative diseases using novel viral vector platforms.
Founded
2020
Focus
RNA & Gene Therapy
About
Develops gene therapies for neurodegenerative diseases using novel viral vector platforms.
Funding History
2Total raised: $5.3M
Grant$1.8MNational Institutes of Health (NIH)Jun 15, 2023
Seed$3.5MY CombinatorMay 15, 2022
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile